Business Description
EKF Diagnostics Holdings PLC
ISIN : GB0031509804
Description
EKF Diagnostics Holdings PLC is engaged in the field of medical diagnostics. Its businesses are Point-of-Care, Central Laboratory, Life Sciences, and Contract Manufacturing. It caters to companies focused on areas such as diabetes, Hematology, Infectious diseases, Clinical Chemistry, Life Sciences OEM, Sports medicine, Custom Bioprocessing, and Others. The company derives its income from its sales in the United States. Its other markets include Germany, Poland, and Russia.
Financial Strength
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 6.09 | |||||
| Equity-to-Asset | 0.87 | |||||
| Debt-to-Equity | 0.02 | |||||
| Debt-to-EBITDA | 0.13 | |||||
| Interest Coverage | 38.64 | |||||
| Piotroski F-Score | 7/9 | |||||
| Altman Z-Score | 7.73 | |||||
| Beneish M-Score | -3.05 | |||||
| WACC vs ROIC | ||||||
Growth Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -6.5 | |||||
| 3-Year EBITDA Growth Rate | -27.2 | |||||
| 3-Year EPS without NRI Growth Rate | -30.7 | |||||
| 3-Year Book Growth Rate | -4.7 | |||||
| Future 3-5Y EPS without NRI Growth Rate | 25.89 | |||||
| Future 3-5Y Total Revenue Growth Rate | 5.87 |
Momentum Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 65.94 | |||||
| 9-Day RSI | 62.83 | |||||
| 14-Day RSI | 58.21 | |||||
| 6-1 Month Momentum % | -7.55 | |||||
| 12-1 Month Momentum % | -19.23 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 4.6 | |||||
| Quick Ratio | 3.08 | |||||
| Cash Ratio | 1.41 | |||||
| Days Inventory | 119.6 | |||||
| Days Sales Outstanding | 48.27 | |||||
| Days Payable | 79.6 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Dividend Growth Rate | 6.3 | |||||
| 3-Year Average Share Buyback Ratio | 0.1 | |||||
| Shareholder Yield % | -1.26 |
Profitability Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 47.41 | |||||
| Operating Margin % | 12.74 | |||||
| Net Margin % | 9.37 | |||||
| FCF Margin % | 12.71 | |||||
| ROE % | 7.16 | |||||
| ROA % | 5.91 | |||||
| ROIC % | 9.63 | |||||
| ROC (Joel Greenblatt) % | 16.16 | |||||
| ROCE % | 7.58 | |||||
| Years of Profitability over Past 10-Year | 6 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 24.91 | |||||
| Forward PE Ratio | 18.71 | |||||
| PE Ratio without NRI | 21.08 | |||||
| PS Ratio | 2.42 | |||||
| PB Ratio | 1.8 | |||||
| Price-to-Tangible-Book | 3.16 | |||||
| Price-to-Free-Cash-Flow | 19.57 | |||||
| Price-to-Operating-Cash-Flow | 10.96 | |||||
| EV-to-EBIT | 22.1 | |||||
| EV-to-EBITDA | 11.94 | |||||
| EV-to-Revenue | 2.33 | |||||
| EV-to-FCF | 18.55 | |||||
| Price-to-Projected-FCF | 1.13 | |||||
| Price-to-Median-PS-Value | 0.9 | |||||
| Price-to-Graham-Number | 1.66 | |||||
| Price-to-Net-Current-Asset-Value | 10.53 | |||||
| Earnings Yield (Greenblatt) % | 4.53 | |||||
| FCF Yield % | 5.17 | |||||
| Forward Rate of Return (Yacktman) % | 25.17 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
EKF Diagnostics Holdings PLC Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 59.676 | ||
| EPS (TTM) (€) | 0.012 | ||
| Beta | 0.29 | ||
| Volatility % | 34.23 | ||
| 14-Day RSI | 58.21 | ||
| 14-Day ATR (€) | 0.007863 | ||
| 20-Day SMA (€) | 0.3011 | ||
| 12-1 Month Momentum % | -19.23 | ||
| 52-Week Range (€) | 0.266 - 0.388 | ||
| Shares Outstanding (Mil) | 453.73 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 7 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
EKF Diagnostics Holdings PLC Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
EKF Diagnostics Holdings PLC Stock Events
| Event | Date | Price(€) | ||
|---|---|---|---|---|
| No Event Data | ||||
EKF Diagnostics Holdings PLC Frequently Asked Questions
What is EKF Diagnostics Holdings PLC(FRA:LYF)'s stock price today?
The current price of FRA:LYF is €0.32. The 52 week high of FRA:LYF is €0.39 and 52 week low is €0.27.
When is next earnings date of EKF Diagnostics Holdings PLC(FRA:LYF)?
The next earnings date of EKF Diagnostics Holdings PLC(FRA:LYF) is 2025-03-20 Est..
Does EKF Diagnostics Holdings PLC(FRA:LYF) pay dividends? If so, how much?
EKF Diagnostics Holdings PLC(FRA:LYF) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers